ARHGDIA Antikörper
Kurzübersicht für ARHGDIA Antikörper (ABIN6989737)
Target
Alle ARHGDIA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-204 of human ARHGDIA (NP_001172006.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
IF(ICC) 1:50-200
IF() -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- ARHGDIA (rho GDP Dissociation Inhibitor (GDI) alpha (ARHGDIA))
-
Andere Bezeichnung
- ARHGDIA
-
Hintergrund
-
Synonyms: ARHGDIA,GDIA1,HEL-S-47e,NPHS8,RHOGDI,RHOGDI-1
Background: This gene encodes a protein that plays a key role in the regulation of signaling through Rho GTPases. The encoded protein inhibits the disassociation of Rho family members from GDP (guanine diphosphate), thereby maintaining these factors in an inactive state. Activity of this protein is important in a variety of cellular processes, and expression of this gene may be altered in tumors. Mutations in this gene have been found in individuals with nephrotic syndrome, type 8. Alternate splicing results in multiple transcript variants.
-
Gen-ID
- 396
-
UniProt
- P52565
-
Pathways
- Neurotrophin Signalübertragung
Target
-